Shares of Agilon Health, Inc. (NYSE:AGL – Get Free Report) have received a consensus recommendation of “Hold” from the fifteen brokerages that are currently covering the company, Marketbeat.com reports. Two analysts have rated the stock with a sell rating, eight have given a hold rating and five have given a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $58.7273.
Several brokerages recently commented on AGL. Weiss Ratings cut shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 27th. Barclays upgraded shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 target price on the stock in a research report on Tuesday, May 26th. Jefferies Financial Group upgraded shares of Agilon Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $27.50 to $48.00 in a research report on Thursday, May 7th. Wall Street Zen raised Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Finally, Citigroup restated a “neutral” rating and issued a $80.00 price target (up from $18.75) on shares of Agilon Health in a report on Friday, May 15th.
Read Our Latest Analysis on Agilon Health
Institutional Inflows and Outflows
Agilon Health Stock Performance
Shares of AGL stock opened at $96.39 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.08. The stock has a 50 day simple moving average of $47.53 and a 200-day simple moving average of $27.57. The company has a market cap of $1.61 billion, a price-to-earnings ratio of -4.47 and a beta of 3.00. Agilon Health has a 12-month low of $7.48 and a 12-month high of $99.14.
Agilon Health (NYSE:AGL – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. On average, equities analysts forecast that Agilon Health will post -3.5 EPS for the current year.
About Agilon Health
Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.
Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.
Featured Articles
- Five stocks we like better than Agilon Health
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Receive News & Ratings for Agilon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilon Health and related companies with MarketBeat.com's FREE daily email newsletter.
